Pregabalin Capsule
Product Images NDC 80425-0029

Product Visual Gallery

This gallery contains 15 technical images submitted to the FDA as part of the official labeling for Pregabalin (NDC 80425-0029). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Advanced Rx Of Tennessee, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Fig 1

FDA Label Image

Fig 10

FDA Label Image

Fig 11

FDA Label Image

Fig 12

FDA Label Image

Fig 2

FDA Label Image

Fig 3

FDA Label Image

Fig 4

Percentage of patients improved in pain from baseline after receiving treatment with either 200mg or 100mg of Pregabalin three times a day, or a placebo, is provided in the text. There is also some illegible characters.*

FDA Label Image

Fig 5

FDA Label Image

Fig 6

This appears to be a table of data that compares multiple studies using different doses of a medication with a placebo. The table shows the percentage of participants experiencing a certain outcome in each study group. The study with the highest dose of the medication shows a statistically significant difference compared to the placebo group.*

FDA Label Image

Fig 7

FDA Label Image

Fig 9

FDA Label Image

Formula

This appears to be a formula for estimating creatinine clearance (CLCr) based on age, weight, and serum creatinine levels in adult patients. However, the text is incomplete and lacks context or instructions on how to use the formula.*

FDA Label Image

Pregabalin 75mg Cap Qty 60 80425 0029

FDA Label Image

Pregabalin 75mg Cap Qty 90 80425 0029

FDA Label Image

Structure

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.